Honghu Tang Selected Research

ruzinurad

1/2022

Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Honghu Tang Research Topics

Disease

3	Gout 01/2022 - 01/2021
2	Rheumatoid Arthritis 10/2022 - 03/2016
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 10/2022
1	Thrombocytopenia (Thrombopenia) 10/2022
1	Dental Caries (Decay, Dental) 10/2022
1	Sjogren's Syndrome (Sjogren Syndrome) 10/2022
1	Hyperuricemia 01/2022
1	Synovitis 12/2020
1	Renal Insufficiency (Renal Failure) 03/2020
1	Hepatitis C 03/2020
1	Autoimmune Diseases (Autoimmune Disease) 03/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2019
1	Reactive Arthritis (Reiter Disease) 11/2017
1	Meningitis 01/2015

Drug/Important Bio-Agent (IBA)

2	Uric Acid (Urate)IBA 01/2022 - 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2022
1	Antinuclear AntibodiesIBA 10/2022
1	Febuxostat FDA Link 01/2022
1	ruzinuradIBA 01/2022
1	Cystatin CIBA 05/2021
1	LigandsIBA 05/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2021
1	Biomarkers (Surrogate Marker)IBA 05/2021
1	Interleukin-8 (Interleukin 8)IBA 05/2021
1	ChemokinesIBA 05/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2021
1	Interleukin-1beta (Interleukin 1 beta)IBA 05/2021
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	AntibodiesIBA 03/2020
1	interleukin-21 (interleukin 21)IBA 03/2019
1	CytokinesIBA 03/2019
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 11/2017
1	Infliximab (Remicade)FDA Link 03/2016
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2015